Cramer gestern:
"...Some stocks, though, just can't get out of their way and they can undo an entire sector. I can't believe how badly this Valeant (VRX) acts. We had incoming CEO Joe Papa on earlier this week and he explained how there was much to Valeant that the bears didn't realize, including lots of good drugs in the pipeline.
It hasn't mattered. The stock of Valeant is back to its old bad ways as an extremely negative article in The New York Times said the drug price gouging that Valeant admitted to hasn't been rolled back yet -- something that Papa promised would happen. At the same time, we keep hearing that the health care system is going to be shaken up by either presidential candidate, and that means that all drug prices might need to come down. When that story makes the rounds then you know that the biotechs are going to be punished, and they were all day..."
hat er sogar ausnahmsweise mal recht damit - solange von vrx nicht´s konkretes kommt und sie weiter so viel raum für spekulationen lassen geht es weiter abwärts...ich bleibe dabei, 18 usd sind das nächste ziel...
|